Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.

Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.

Survey shows many teens and young adults support making menstrual products more accessible to fight "period poverty."

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Many women don’t get cervical cancer screening such as Pap tests, or don’t go for follow up diagnostic tests; a new study shows what could happen if all of them did.

Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.

Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

As guest editor for a themed journal issue, Lori Pierce helps highlight the multiple factors that can make cancer care and prevention more equitable and reduce the burden of this disease for all

Vaccination against the coronavirus was much lower in adults and children with sickle cell disease despite a higher risk of severe COVID-19.

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.

How two newly approved gene therapies, including novel technology CRISPR, may help kids and adults with inherited blood disorders

A car accident at age 20 left Sahar Mashhour in the intensive care unit for three months. Almost six years later, Mashhour is still pursuing her passions proving that her disability doesn’t limit her ability, but instead helps her see life through a different lens.

Infants with hemophilia A who received monoclonal antibody emicizumab experienced few bleeding events and no serious complications, a study suggests.